T2DM is characterized by decreased insulin sensitivity of tissues (especially skeletal muscles and liver) with concomitant insulin resistance and impaired insulin secretion by the β-cells of the Langerhans islets in the pancreas [42,43]. The gene discussed is INS; the disease is Insulin resistance.